Dermatology – Q1 2022 Acquisition Activity and Outlook
The 4th quarter of 2021 delivered two reported cardiology platform acquisitions, signaling an imminent wave of increasing private equity investments into the specialty.
The 4th quarter of 2021 delivered two reported cardiology platform acquisitions, signaling an imminent wave of increasing private equity investments into the specialty.
The first quarter of 2022 delivered thirty-five reported behavioral health acquisitions, returning to average deal volume after a spike in activity to end 2021. Mental health and addiction treatment continue to be at the forefront of consolidation. We will highlight a few notable deals from the period.
The 1st quarter of 2022 delivered two reported cardiology partnerships for this specialty in the Early Pioneering lifecycle stage PE interest remains consistent and seems to be building
Washington, DC, (February 14, 2022) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture, and corporate finance services, announced today that Vista Eye Specialists, an ophthalmologic and optomet- ric practice, has been acquired by Atlantic Vision Partners (“AVP”), a portfolio company of Sheridan Capital Partners. FOCUS managing directors, Eric Yetter and Andy Snyder, advised Vista Eye Specialists in this partnership.They are among the most active advisors to ophthal- mologists in transactions with private equity-backed organizations.
Washington, DC, (January 21, 2022) – FOCUS Investment Banking (“FOCUS”), a leading national middle market investment banking firm providing merger, acquisition, divestiture, and corporate finance services, is delighted to be acknowledged as #1 on Axial’s Top Lower Middle Market M&A Advisors list for Q4 2021. This marks the second consecutive quarter the firm has received this recognition.